Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia

Abstract

Adjusting the dose of methotrexate to account for the patient's ability to clear the drug can improve the outcome in children with B-lineage acute lymphoblastic leukemia.